Clinical Trials Logo

Intravenous Drug Usage clinical trials

View clinical trials related to Intravenous Drug Usage.

Filter by:

NCT ID: NCT03981445 Active, not recruiting - Opioid Use Clinical Trials

Integrated HIV Prevention and HCV Care for PWID

M2HepPrEP
Start date: November 14, 2019
Phase: N/A
Study type: Interventional

The objective of this study is to compare and evaluate two strategies of delivering PrEP and Hepatitis C Virus (HCV) treatment to people who inject drugs to determine the best method of providing care. Participants will be randomized to one of two treatment arms: on-site integrated care or off-site referral to specialized care.

NCT ID: NCT03927118 Completed - Clinical trials for Diabetic Macular Edema

Effect of Dexamethasone Implant on Optic Disc

Start date: February 1, 2018
Phase:
Study type: Observational

This study evaluates the effect of dexamethasone implant which is an intraocular corticosteroid on the optic nerve fibers. Retinal nerve fiber thicknesses and optic nerve head pitting rates were measured before and 6 months after the injection.

NCT ID: NCT03567174 Completed - HIV/AIDS Clinical Trials

Building on Needle Exchange to Optimize Prevention & Treatment

Start date: June 22, 2018
Phase: N/A
Study type: Interventional

There are several biomedical interventions that can help people who inject drugs (particularly those with or at risk for HIV), but these services often do not get to the people most in need. In this project investigators propose to determine if delivery of these services to PWID by an integrated care van that is linked to a mobile syringe service program improves clinical outcomes, is feasible and sustainable, and is cost-effective.

NCT ID: NCT03523533 Terminated - Clinical trials for Intravenous Drug Usage

Peripherally Inserted Internal Jugular Catheters: an Observational Study

Start date: August 3, 2018
Phase: N/A
Study type: Interventional

This is an observational study intended to characterize the time-to-placement of peripherally-inserted internal jugular (PIJ) catheters in appropriate patients. As secondary outcomes and to ensure patient safety, the investigators will record and evaluate adverse outcomes, but the study is not powered to detect rare events.

NCT ID: NCT02999217 Recruiting - Clinical trials for Colorectal Neoplasms

Intravenous Iron for Correction of Anaemia After Colorectal Surgery

Start date: October 2016
Phase: Phase 4
Study type: Interventional

This 4-week prospective double blind anaemia management study evaluates the effect of high-dose postoperative intravenous iron vs placebo for patients after colorectal cancer surgery. Patients with preoperative levels of haemoglobin 90-120 g/l will be randomly assigned to receive either 1 g of intravenous iron or equal amount of saline postoperatively. Comparison will be based on the levels of haemoglobin, ferritin and other haematological parameters over time and profile of clinical recovery. The primary end point is that iron isomaltoside given postoperatively is superior to placebo in terms of increase and stability of levels of haemoglobin and other haematological parameters.

NCT ID: NCT01831284 Completed - Clinical trials for Intravenous Drug Usage

Correlates and Consequences of Increased Immune Activation in Injection Drug Users

Start date: December 2012
Phase: N/A
Study type: Observational

The goal of this study is to learn how injection drug use may affect the immune system.

NCT ID: NCT01477905 Completed - Clinical trials for Intravenous Drug Usage

Impact of Priming the Infusion System on the Performance of Target-controlled Infusion of Remifentanil

Start date: March 2011
Phase: N/A
Study type: Interventional

The investigators attempted to determine an adequate priming volume for our infusion system, and investigated the extent of a possible delay of the drug effect, that would result from mechanical defects of the infusion system, with or without priming the infusion system, using direct gravimetrical measurements of virtual infusate amounts during target controlled infusion of 2 remifentanil diluents.